Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
【Why Low ALP Leaves Adults Unable to Walk: Urgent Next Steps】をわかりやすく解説 高血圧・低血圧 更新日 2025/07/16
Low alkaline phosphatase (ALP) can leave adults unable to walk because ALP is essential for bone mineralization, and persistently low levels may signal adult hypophosphatasia (HPP), a rare genetic condition that causes bones to soften, fracture easily, and hurt severely. Adults with HPP often report muscle weakness, waddling gait, foot and thigh pain, recurrent stress fractures, and progressive difficulty standing or walking. Other causes of low ALP include severe malnutrition, zinc or magnesium deficiency, hypothyroidism, Wilson disease, celiac disease, anemia, and certain medications like bisphosphonates, corticosteroids, or high-dose vitamin D.
Because mobility loss can escalate quickly, urgent evaluation matters: repeat ALP testing, measure vitamin B6 (PLP) and urine phosphoethanolamine, check calcium, phosphate, PTH, and vitamin D, and pursue ALPL genetic testing when HPP is suspected. Imaging for stress fractures and referral to endocrinology, metabolic bone disease specialists, or genetics can prevent further deterioration. Treatment depends on cause: nutrient repletion, thyroid or liver management, medication review, and for HPP, enzyme replacement therapy (asfotase alfa) along with physical therapy, pain control, and fall prevention.
Avoid bisphosphonates in HPP, since they can worsen bone fragility. Seek immediate care for sudden inability to bear weight, severe unrelenting bone pain, suspected fracture, or rapid functional decline.
Important note: seek urgent care for new inability to walk, suspected fractures, or severe bone pain, and share your full medication and supplement list with your clinician.Persistently low alkaline phosphatase (ALP) can rob adults of the ability to walk because this enzyme is essential for bone mineralization, and low levels may point to adult hypophosphatasia (HPP), a rare genetic disorder that softens bones and triggers painful stress fractures, muscle weakness, and a waddling gait. Other culprits include severe malnutrition, zinc or magnesium deficiency, hypothyroidism, Wilson disease, celiac disease, anemia, and medications such as bisphosphonates, corticosteroids, or high-dose vitamin D. Urgent workup should include repeat ALP testing, vitamin B6 (PLP), urine phosphoethanolamine, calcium, phosphate, PTH, vitamin D, imaging for fractures, and ALPL genetic testing when HPP is suspected, with treatment ranging from nutrient repletion to enzyme replacement therapy (asfotase alfa). Critically, bisphosphonates must be avoided in HPP because they worsen bone
Alkaline phosphatase (ALP) is an enzyme found in many tissues, especially the liver and bones. When ALP levels fall below the normal range—a condition known as hypophosphatasia—bone and muscle health can be seriously affected. In adults, very low ALP can lead to pain, fractures, muscle weakness and, in severe cases, difficulty or inability to walk. Understanding why this happens and what to do next can help you or a loved one get timely care.
Role of ALP
Normal vs. Low ALP Levels
Adults with chronically low ALP often struggle with:
Bone Weakness and Fractures
Muscle Weakness and Pain
Joint and Tendon Problems
Neurological Symptoms (Rare)
Genetic Hypophosphatasia
Malnutrition and Vitamin Deficiencies
Endocrine and Metabolic Disorders
Medications
Chronic Illness
If you have been told your ALP is low, pay attention to:
Even if walking is only mildly uncomfortable now, these issues can progress. Early action can prevent serious complications.
Confirm Your Lab Results
Discuss Genetic Testing
Imaging and Bone Density
Specialist Referral
Optimize Nutrition and Supplements
Physical Therapy and Mobility Aids
Medication and Enzyme Replacement
Even though it’s important not to panic, get urgent help if you experience:
If you’re unsure what to do next, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you clarify which specialists or tests you may need, based on your symptoms.
Low alkaline phosphatase (ALP) is not common, but when it’s persistent and significant, it can severely compromise bone health, muscle strength and walking ability. Prompt evaluation, specialist referrals and a coordinated treatment plan can:
If you or someone you care about has low ALP and is experiencing any difficulty walking, don’t delay. Speak to a doctor right away about the steps outlined here, especially if you notice worsening pain, new fractures or any life-threatening symptoms. Early intervention is key to preserving mobility and quality of life.
(References)
* Mornet E. Hypophosphatasia. Orphanet J Rare Dis. 2007 Oct 4;2:40. doi: 10.1186/1750-1172-2-40. Epub 2007 Oct 4. PMID: 17916236; PMCID: PMC2164941.
* Colazo JM, Hu JR, Dahir KM, Simmons JH. Neurological symptoms in Hypophosphatasia. Osteoporos Int. 2019 Feb;30(2):469-480. doi: 10.1007/s00198-018-4691-6. Epub 2018 Sep 13. PMID: 30215116.
* Kishnani PS, Rockman-Greenberg C, Rauch F, Bhatti MT, Moseley S, Denker AE, Watsky E, Whyte MP. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia. Bone. 2019 Apr;121:149-162. doi: 10.1016/j.bone.2018.12.011. Epub 2018 Dec 18. PMID: 30576866.
* Pendleton EG, Nichenko AS, Mcfaline-Figueroa J, Raymond-Pope CJ, Schifino AG, Pigg TM, Barrow RP, Greising SM, Call JA, Mortensen LJ. Compromised Muscle Properties in a Severe Hypophosphatasia Murine Model. Int J Mol Sci. 2023 Nov 2;24(21). doi: 10.3390/ijms242115905. Epub 2023 Nov 2. PMID: 37958888; PMCID: PMC10649932.
* Alsarraf F, Ali DS, Almonaei K, Al-Alwani H, Khan AA, Brandi ML. Hypophosphatasia: presentation and response to asfotase alfa. Osteoporos Int. 2024 Apr;35(4):717-725. doi: 10.1007/s00198-023-06943-z. Epub 2023 Nov 23. PMID: 37993691.
* Lee D, Park SY, Kim HS, Kang S. Short stature with low serum alkaline phosphatase activity: a case report of hypophosphatasia. Ann Pediatr Endocrinol Metab. 2023 Dec;28(4):312-317. doi: 10.6065/apem.2244294.147. Epub 2023 Dec 31. PMID: 38173385; PMCID: PMC10765032.
* Dahir KM, Shannon A, Dunn D, Voegtli W, Dong Q, Hasan J, Pradhan R, Pelto R, Pan WJ. Safety, pharmacokinetics, and pharmacodynamics of efzimfotase alfa, a second-generation enzyme replacement therapy: phase 1, dose-escalation study in adults with hypophosphatasia. J Bone Miner Res. 2024 Sep 26;39(10):1412-1423. doi: 10.1093/jbmr/zjae128. PMID: 39135540; PMCID: PMC11425692.
* Seefried L, Genest F, Hofmann C, Brandi ML, Rush E. Diagnosis and Treatment of Hypophosphatasia. Calcif Tissue Int. 2025 Mar 6;116(1):46. doi: 10.1007/s00223-025-01356-y. Epub 2025 Mar 6. PMID: 40047955; PMCID: PMC11885340.
* Moss KE, Keen R, Fang S, Zygouras A, Javaid MK, Geberhiwot T, Poole KES, Selby P, Walsh JS, Bubbear JS. Mobility and Quality of Life in Adults with Paediatric-Onset Hypophosphatasia Treated with Asfotase Alfa: Results from UK Managed Access Agreement. Adv Ther. 2025 May;42(5):2429-2444. doi: 10.1007/s12325-025-03168-w. Epub 2025 Mar 26. PMID: 40138164; PMCID: PMC12006239.
* Padidela R, Bishop N, Arundel P, Fang S, Zygouras A, Mughal MZ, Shaw N, Saraff V. Mobility and Quality of Life in Children with Paediatric-Onset Hypophosphatasia Treated with Asfotase Alfa: Results from UK Managed Access Agreement. Adv Ther. 2025 Jul;42(7):3528-3546. doi: 10.1007/s12325-025-03225-4. Epub 2025 May 29. PMID: 40439960; PMCID: PMC12182503.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.